The efficacy, safety, and tolerability o
β
Priya S. Kishnani; Barbara R. Sommer; Benjamin L. Handen; Benjamin Seltzer; Geor
π
Article
π
2009
π
John Wiley and Sons
π
English
β 177 KB
π 1 views
## Abstract The objective of our study was to assess the efficacy and safety of donepezil in young adults with Down syndrome (DS) but no evidence of Alzheimer disease (AD). A 12βweek, randomized, doubleβblind, placeboβcontrolled study with a 12βweek, openβlabel extension was conducted. The interven